The Grand Rounds in Urology™ (GRU) Community is a premier network for urologists, medical oncologists, radiation oncologists, and other healthcare providers to keep up-to-date with best practices and current clinical updates for the treatment of urologic diseases and conditions, especially genitourinary cancers. GRU provides dissemination of knowledge through online content, live meetings, lectures, conversations, information sharing, and constructive debates, ultimately improving physician performance and patient outcomes throughout the world. Members of the GRU community receive timely notifications of important upcoming meetings, additional coursework, CME opportunities, and educational materials relating to urology.

E. David Crawford, MD, Professor of Surgery, Urology, and Radiation Oncology, and Head of the Section of Urologic Oncology at the University of Colorado Denver in Denver, Colorado, serves as Editor in Chief.

GRU accomplishes its mission in the following ways:

Live Meetings: GRU is an organizer and host of international conferences and symposia that bring together the top thought leaders in the treatment of urologic disease. Our meetings focus on current best treatment practices, as well as future trends and directions. These educational programs offer highly interactive dialog with state-of-the-art presentations.

Valuable Information and Online Learning Products: Virtual Grand Rounds, Platinum Lecture Series, Ask the Expert, as well as presentations from international meetings provide the resources urologists need to stay informed. Online courses, CME and non-CME, provide urologists with the best practices for treating patients.

Networking: GRU serves to constantly connect professional learners, faculty experts, and industry partners through its live and virtual activities. These opportunities facilitate high-level collaborations to evolve best practices in urologic care.

Follow us on Twitter!

Rivanna Health Publication’s Prostatepedia features informal conversations with doctors, patients, and activists about prostate cancer. Each month, we tackle a different topic facing prostate cancer patients today—from how imaging has impacted treatment, to dealing with erectile dysfunction after radiation or surgery, and to the evolving field of immunotherapy.

IOS Press is headquartered in Amsterdam, serving the information needs of scientific and medical communities worldwide. IOS Press publishes over 100 international journals and about 75 book titles each year on subjects ranging from medicine and the natural sciences to computer sciences and mathematics. The company’s two journals, Bladder Cancer and Kidney Cancer, are forums for important scientific advancements and the advocacy communities in these fields. Bladder Cancer and Kidney Cancer facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis, and treatment of tumors of the bladder and the kidney, respectively. IOS Press partners with Grand Rounds in Urology to provide access to the latest research (abstracts) published in these journals.

In 2008, when physician leaders of member urology practices began to recognize the need for a formal association to help meet the challenges of the future, the Large Urology Group Practice Association (LUGPA) was established with the purpose of enhancing communication among large groups, allowing for benchmarking of operations, promoting quality clinical outcomes, developing new opportunities, and improving advocacy in the legislative and regulatory arenas. LUGPA has modified its bylaws and now welcomes memberships for all physician colleagues, regardless of size. All urologists may benefit from the growing LUGPA network.

Prostate Conditions Education Council (PCEC) was founded in 1989, and is a non-profit 501-3c organization. A national organization committed to men’s health, PCEC is the nation’s leading resource for information on prostate health. The PCEC is dedicated to saving lives through awareness and the education of men, the women in their lives, as well as the medical community about prostate cancer prevalence, the importance of early detection, available treatment options, and other men’s health issues. The Council – comprised of a consortium of leading physicians, health educators, scientists, and prostate cancer advocates – aims to conduct nationwide screenings for men and perform research that will aid in the detection and treatment of prostate conditions.

The PCa Commentary was commenced in October 2002 as a project to bring to clinicians working the prostate cancer field new information about clinically relevant developments in diagnosis, staging, imaging, and treatment  —  and place this information into the context of a basic science background. The articles are based on literature research of a variety of sources which the busy clinician may not have the time to peruse. In most instances the text has been reviewed by an expert in the subject under discussion. The goal is to present practice relevant data concisely and accurately.